Applied DNA Sciences (APDN) Receives Coverage Optimism Rating of 0.14

Press coverage about Applied DNA Sciences (NASDAQ:APDN) has been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies positive and negative media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Applied DNA Sciences earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned media headlines about the technology company an impact score of 45.9064772246744 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Shares of Applied DNA Sciences (NASDAQ APDN) traded down $0.04 on Friday, hitting $1.57. The stock had a trading volume of 207,200 shares, compared to its average volume of 340,925. The firm has a market cap of $43.94, a P/E ratio of -3.20 and a beta of -0.58. Applied DNA Sciences has a one year low of $0.90 and a one year high of $3.45.

Applied DNA Sciences (NASDAQ:APDN) last issued its earnings results on Thursday, December 28th. The technology company reported ($0.10) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.10). The company had revenue of $1.15 million for the quarter. Applied DNA Sciences had a negative return on equity of 141.55% and a negative net margin of 270.60%. analysts anticipate that Applied DNA Sciences will post -0.35 EPS for the current year.

Several analysts have issued reports on the company. Maxim Group set a $5.00 price objective on Applied DNA Sciences and gave the stock a “buy” rating in a report on Friday, December 8th. ValuEngine upgraded Applied DNA Sciences from a “strong sell” rating to a “sell” rating in a report on Tuesday, October 3rd.

TRADEMARK VIOLATION NOTICE: “Applied DNA Sciences (APDN) Receives Coverage Optimism Rating of 0.14” was originally reported by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://transcriptdaily.com/2018/01/12/applied-dna-sciences-apdn-receives-coverage-optimism-rating-of-0-14.html.

About Applied DNA Sciences

Applied DNA Sciences, Inc is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.

Insider Buying and Selling by Quarter for Applied DNA Sciences (NASDAQ:APDN)

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply